Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure.

MLA

Makarovskiy, A. N., et al. “Survival of Docetaxel-Resistant Prostate Cancer Cells in Vitro Depends on Phenotype Alterations and Continuity of Drug Exposure.” Cellular & Molecular Life Sciences, vol. 59, no. 7, July 2002, pp. 1198–211. EBSCOhost, https://doi.org/10.1007/s00018-002-8498-3.

APA

Makarovskiy, A. N., Siryaporn, E., Hixson, D. C., & Akerley, W. (2002). Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure. Cellular & Molecular Life Sciences, 59(7), 1198–1211. https://doi.org/10.1007/s00018-002-8498-3

Chicago

Makarovskiy, A. N., E. Siryaporn, D. C. Hixson, and W. Akerley. 2002. “Survival of Docetaxel-Resistant Prostate Cancer Cells in Vitro Depends on Phenotype Alterations and Continuity of Drug Exposure.” Cellular & Molecular Life Sciences 59 (7): 1198–1211. doi:10.1007/s00018-002-8498-3.